AMGEN INTRODUCES COMPREHENSIVE FINANCIAL ASSISTANCE PROGRAMS FOR CANCER PATIENTS

Amgen announced Amgen Oncology Assistance (AOA), a comprehensive, multi-faceted financial assistance program that will include a "cap" on out-of-pocket co-payments for cancer patients receiving Vectibix (panitumumab). Through AOA, patients who are uninsured, underinsured, or unable to afford their insurance co-payments will receive help obtaining financial support for Amgen's cancer medicines.

Amgen (http://www.amgen.com/media/media_pr_detail.jsp?year=2006&releaseID=909845)